| Literature DB >> 24731887 |
Richard Sullivan1, Rajendra A Badwe2, Goura K Rath3, C S Pramesh2, V Shanta4, Raghunadharao Digumarti5, Anil D'Cruz2, Suresh C Sharma6, Lokesh Viswanath7, Arun Shet8, Manavalan Vijayakumar7, Grant Lewison9, Mammen Chandy2, Priyadarshini Kulkarni10, M R Bardia11, Shaleen Kumar12, Rajiv Sarin2, Paul Sebastian13, Preet K Dhillon14, Preetha Rajaraman15, Edward L Trimble16, Ajay Aggarwal9, D K Vijaykumar17, Arnie D Purushotham9.
Abstract
Over the past 20 years, cancer research in India has grown in size and impact. Clinicians, scientists, and government and state policy makers in India have championed cancer research, from studies to achieve low-tech, large-scale health outcomes to some of the most advanced areas of fundamental cancer science. In this paper, we frame public policy discussions about cancer with use of an in-depth analysis of research publications from India. Cancer research in India is a complex environment that needs to balance public policy across many competing agendas. We identify major needs across these environments such as those for increased research capacity and training and protected time for clinical researchers; for more support from states and enhanced collaborative funding programmes from government; for development of national infrastructures across a range of domains (ie, clinical trials, tissue banking, registries, etc); and for a streamlined and rational regulatory environment. We also discuss improvements that should be made to translate research into improvements in cancer outcomes and public health.Entities:
Mesh:
Year: 2014 PMID: 24731887 DOI: 10.1016/S1470-2045(14)70109-3
Source DB: PubMed Journal: Lancet Oncol ISSN: 1470-2045 Impact factor: 41.316